Targeting autophagy impairment improves the phenotype of a novel CLN8 zebrafish model
- PMID: 38763444
- PMCID: PMC11163972
- DOI: 10.1016/j.nbd.2024.106536
Targeting autophagy impairment improves the phenotype of a novel CLN8 zebrafish model
Abstract
CLN8 is an endoplasmic reticulum cargo receptor and a regulator of lysosome biogenesis whose loss of function leads to neuronal ceroid lipofuscinosis. CLN8 has been linked to autophagy and lipid metabolism, but much remains to be learned, and there are no therapies acting on the molecular signatures in this disorder. The present study aims to characterize the molecular pathways involved in CLN8 disease and, by pinpointing altered ones, to identify potential therapies. To bridge the gap between cell and mammalian models, we generated a new zebrafish model of CLN8 deficiency, which recapitulates the pathological features of the disease. We observed, for the first time, that CLN8 dysfunction impairs autophagy. Using autophagy modulators, we showed that trehalose and SG2 are able to attenuate the pathological phenotype in mutant larvae, confirming autophagy impairment as a secondary event in disease progression. Overall, our successful modeling of CLN8 defects in zebrafish highlights this novel in vivo model's strong potential as an instrument for exploring the role of CLN8 dysfunction in cellular pathways, with a view to identifying small molecules to treat this rare disease.
Keywords: Autophagy; Drug screening; Neuronal ceroid lipofuscinosis 8; Zebrafish.
Copyright © 2023. Published by Elsevier Inc.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no conflicts of interest.
Figures









References
-
- Bartsch U., Galliciotti G., Jofre G.F., Jankowiak W., Hagel C., Braulke T. Apoptotic photoreceptor loss and altered expression of lysosomal proteins in the nclf mouse model of neuronal ceroid lipofuscinosis. Invest. Ophthalmol. Vis. Sci. 2013;54(10):6952–6959. doi: 10.1167/iovs.13-12945. - DOI - PubMed
-
- Bellusci L., Laurino A., Sabatini M., Sestito S., Lenzi P., Raimondi L., Rapposelli S., Biagioni F., Fornai F., Salvetti A., Rossi L., Zucchi R., Chiellini G. New insights into the potential roles of 3-iodothyronamine (T1AM) and newly developed thyronamine-like TAAR1 agonists in neuroprotection. Front. Pharmacol. 2017;8:905. doi: 10.3389/fphar.2017.00905. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous